Aarti Patel

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Joe Bentz, Michael O′Connor, Dallas Bednarczyk et al. · Drug Metabolism and Disposition · 2013 · 147 citations · Full text

Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development

Carole Shardlow, Grant T. Generaux, Aarti Patel et al. · Drug Metabolism and Disposition · 2013 · 40 citations

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies

Xavier Pépin, Leon Aarons, Yuya Wang et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2020 · 36 citations · Full text

Pharmacokinetic Modeling, Prediction Accuracy, Modelling Strategies +9

Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation

Zoe Riches, Jackie C. Bloomer, Aarti Patel et al. · Xenobiotica · 2009 · 30 citations

Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P ₁ Agonists

S. Taylor, Emmanuel H. Demont, James R. Gray et al. · Journal of Medicinal Chemistry · 2015 · 16 citations · Full text